Vigil Neuro (VIGL) - Kompaniyaning sof foydasi

vigilneuro.com (VIGL) kompaniyasining rasmiy ramzlari

Barqaror yetakchilik va investorlar qo'llab-quvvatlashi Vigil Neuroscience (VIGL) kompaniyasining yalpi foyda dinamikasini harakatga keltirmoqda, buni GURU.Markets grafigi ko'rsatadi, unda joriy qiymat -0.09 ni tashkil etgan. Biznes Massachusets shtatidagi markazlar orqali faoliyat yuritib, neyronlarni tiklash uchun immunologik terapiyalarni ishlab chiqmoqda. Yuqori masshtablanish imkoniyati molekulyar patentlar orqali ta'minlangan bo'lib, bu kompaniyaga ishlab chiqarish xarajatlarini past darajada saqlagan holda narxlarni belgilash imkoniyatini yaratadi.

VIGL Vigil Neuroscience Inc. Sof foyda (04.07.2022 - 16.08.2025)

vigilneuro.com (VIGL) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Vigil Neuroscience, Inc.|VIGL - Konsensus maqsadli narx
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Vigil Neuroscience, Inc.|VIGL - Korxona qiymati
- balans kapitallashuvi ko'rsatkichlari:
Aksiya hisobiga sof aktivlar Vigil Neuroscience|VIGL - Balans kapitallashuvi|Bozor qiymatining xususiy kapitalga nisbati vigilneuro.com|VIGL - Kompaniyaning umumiy aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati koeffitsiyenti Vigil Neuroscience|VIGL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc.|VIGL - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Vigil Neuroscience, Inc.|VIGL - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Vigil Neuroscience|Shoshilinch likvidlik vigilneuro.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
VIGL - Sof daromad
Kompaniyaning jamlanma tahlili:Vigil Neuro (VIGL)
Vigil Neuroscience, Inc. seriyali mahsuloti

Vigil Neuroscience (VIGL) kompaniyasining noyob nevrologik kasalliklar segmentidagi biofarmatsevtika ishlanmalarining yuqori masshtablanuvchanligi dori vositalari tijoratlashtirilganda marjalarning keskin o'sishi uchun imkoniyat yaratadi. Ushbu ko'rsatkich davr uchun yakuniy moliyaviy natijani raqamlashtirib, daromadlar bo'yicha matematik kutishni aniqlash va kompaniyaning sof foydasi tahlili orqali o'rtacha qiymatlarga nisbatan katastrofik pasayishlar xavfini baholash imkonini beradi.

Asosiy raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|Sof daromad NBIX|Kompaniyaning sof foydasi RGC|Sof foyda AXSM|Sof moliyaviy natija ACADIA Pharma|Sof foyda XENE (Xenon Pharmaceuticals Inc)|Yillik sof foyda Viking Therapeutics Corp|Supernus Pharmaceuticals - Sof foyda|Sof moliyaviy natija catalystpharma.com CPRX|Denali Therapeutics Inc. (DNLI) - Kompaniyaning sof foydasi|HRMY (Harmony Biosciences Inc) - Kompaniyaning sof foydasi|Sof daromad BHVN|AMLX: Yakuniy foyda|Kompaniyaning sof foydasi Trevi Therapeutics (TRVI)|praxismedicines.com - Kompaniya foydasi|Sof foyda AVXL (Anavex Life Sciences Corp.)|CeriBell Inc (CBLL) - Kompaniyaning sof daromadi|PRTA: Sof daromad|ALEC - Sof foyda|Annexon, Inc. (ANNX) - Kompaniyaning sof foydasi|Omeros - Yakuniy foyda|Kompaniyaning sof foydasi Neurogene|Kompaniyaning sof daromadi AC Immune S.A. ACIU|Kompaniyaning sof foydasi Voyager Pharma (VYGR)|Sof moliyaviy natija Neumora Corp|Sof foyda SCLX (Scilex Holding Company)|TVGN - Sof daromad|Alpha Cognition Corp - Sof foyda|Sof moliyaviy natija cogrx.com CGTX|IKT: Sof foyda|Kompaniyaning sof daromadi Cassava Pharma (SAVA)|Kompaniyaning sof foydasi Assertio Holdings|Kompaniya foydasi COYA (Coya)|Sof foyda VTGN|Sof daromad ovidrx.com OVID|Sof foyda ABOS (Acumen Pharma)|CervoMed Corporation (CRVO) - Kompaniyaning sof daromadi|ATHE: Sof daromad|CLNN: Kompaniyaning sof foydasi|PEPG: Sof foyda|JUNS - Sof moliyaviy natija|RLMD (Relmada) - Sof foyda|ANVS - Yillik sof foyda|Kompaniyaning sof foydasi Grace Therapeutics, Inc. (GRCE)|Kompaniyaning sof foydasi AIFF (fireflyneuro.com)|Kompaniyaning sof foydasi Klotho Neurosciences KLTO|NRSN: Kompaniya foydasi|Reviva Pharmaceuticals Holdings - Sof foyda|Kompaniyaning sof daromadi MetaVia Inc|NRXS (NeurAxis, Inc.) - Sof daromad|Helius Medical Technologies (HSDT) - Sof foyda|Kompaniyaning sof foydasi Passage Bio Inc.|NEUP: Yakuniy foyda|Kompaniyaning sof foydasi Minerva Neurosciences Corp (NERV)|ATHA - Kompaniyaning sof daromadi|Addex Therapeutics - Sof daromad|Alzamend Neuro Inc. - Kompaniyaning sof foydasi|Cyclerion - Sof foyda|Sof moliyaviy natija Protagenic Therapeutics PTIX|KTTA: Sof foyda|Yillik sof foyda Cortigent CRGT|ATXI (Avenue Therapeutics) - Sof foyda|brainstorm-cell.com (BCLI) - Sof moliyaviy natija|Kompaniyaning sof foydasi Cara Therapeutics (CARA)|Kompaniyaning sof foydasi CHRO (Chromocell Therapeutics Corp)|Eliem Therapeutics Inc. - Sof daromad|Yakuniy foyda ITCI|LBPH - Kompaniyaning sof foydasi|MRNS (marinuspharma.com) - Kompaniya foydasi|NKGN: Sof foyda|Kompaniyaning sof daromadi NeuroBo Pharmaceuticals Inc (NRBO)|Sof daromad SAGE|Sof foyda Synaptogenix, Inc|Kompaniyaning sof foydasi Trevena, Inc. (TRVN)|WENA (Anew Medical Inc.) - Yakuniy foyda|Kompaniyaning sof foydasi Cerevel Therapeutics, Inc. CERE